ArticleDermatology research and practice2016

Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions.

Vinay SinghPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.